Market players said the statement issued by the government to defuse the tension with the RBI had helped market sentiment
Nifty, Bank Nifty, HCL Technologies, Tata Motors, Hero MotoCorp
As on September 2018, L&T's total order book was at Rs 2.81 trillion, of which 22 per cent was from international orders
Improvement in asset quality led by strong operational growth are key positives for shareholders
The company, however, believes that new model launches and China revival will lead to a reversal in fortunes
The government of Maharashtra had in past shifted APMC from Mumbai to Navi Mumbai ensuring all possible supports to traders and farmers there
The buyback price is at around 28 per cent premium to the current market price of Rs 67 on the Bombay Stock Exchange (BSE).
Institutional demand less than a third of the total issue size of Rs 148-bn
Investor sentiment turned positive after the Finance Ministry issued a statement to dampen concerns over a spat between the government and the RBI
Though management indicated input cost pressure, price hikes and cost efficiency should help protect margins
Government officials have recently called for the RBI to relax its lending restrictions on some banks, and the government has also been trying to trim the RBI's regulatory powers.
Nifty IT index settled 4.2 per cent higher led by gains in Tech Mahindra and Infosys. The Nifty Financial Services index too rose 2.3 per cent led by Indiabulls Housing Finance and HDFC
Indiabulls Housing, UCO Bank, JM Financial Services, Repco Home Finance, HDFC, IndusInd Bank, Edelweiss Financial Services and Bharat Financial Service were up more than 4%.
According to a recent IIFL report, sales of Patanjali products have halved from two year earlier levels.
Tata Global Beverages slipped 9% to Rs 206, while Emami down 4.5% to Rs 386 on the BSE in intra-day trade.
The stock moved higher by 8% to Rs 741 on the BSE after the company's Ebitda margins in September quarter expanded 240bps at 18.8%
Delay of 12-18 months expected; stakeholders trying to reach consensus
The stock surged 14% to Rs 769 on the BSE after the company reported a better-than-expected 39% Y-o-Y jumped in net profit at Rs 2.12 billion in September quarter, on back of higher revenue.
The stock slipped 7% to Rs 2,425 on the BSE after the pharmaceutical company said US health regulator issued eight observations after inspecting its formulations plant at Duvvada, Visakhapatnam.
The stock was down 4% to Rs 265, extending its previous day's 4% decline on the BSE after the company's OFS of its equity shares began at price of Rs 266 per share today.